Oxford-AstraZeneca begins work on vaccine to target Omicron
London, Dec 23 (IANS) Faced with a vaccine evading Omicron variant, Oxford university and AstraZeneca announced that they have begun the work to develop a Covid shot that specifically targets the new strain. Early this month, all major drug makers including